Wooldridge James 4
4 · Checkmate Pharmaceuticals, Inc. · Filed Apr 28, 2022
Insider Transaction Report
Form 4
Wooldridge James
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2021-03-04+54,600→ 54,600 totalExercise: $13.50Exp: 2031-03-03→ Common Stock (54,600 underlying)
Footnotes (1)
- [F1]This stock option shall vest 25% on the first anniversary of the vesting start date of March 5, 2021 and in substantially equal monthly installments for a period of 36 months thereafter, subject to the Reporting Persons continued service through such date.